comparemela.com

Latest Breaking News On - Korea dementia research center - Page 1 : comparemela.com

Magnetic Nanotech Removes Inflammatory Triggers from Blood

A group of researchers from the Seoul National University Bundang Hospital and UNIST led by Professors Joo Hun Kang and Jinmyoung Joo, along with Professor Jae Hyuk Lee, have developed a novel technology that can eliminate agents that cause inflammation from extracorporeal blood.

South-korea
Korea
Joo-hun-kang
Jinmyoung-joo
Superparamagnetic-nanoclusters-spncs
Suhyun-kim
Jae-hyuk-lee
Seoul-national-university-bundang-hospital
Department-of-biomedical-engineering
Research-laboratory
Korea-dementia-research-center
Ulsan-national-institute-of-science-technology

Research Unveils New Tech Using Magnetic Nanoclusters for Sepsis

Research Unveils New Tech Using Magnetic Nanoclusters for Sepsis
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South-korea
Korea
Jinmyoung-joo
Jae-hyuk-lee
Suhyun-kim
Joo-hun-kang
Seoul-national-university-bundang-hospital
Posco
Ministry-of-science
Ministry-of-health-welfare
Posco-tj-park-foundation
Korea-health-technology

KAIST Team Finds Childhood Abuse Triggers Mental Diseases

KAIST Team Finds Childhood Abuse Triggers Mental Diseases
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South-korea
Korea
Nam-shik-kim
Suk-chung
National-research-foundation-of-korea
Korea-dementia-research-center
Department-of-biological-sciences
Korea-advanced-institute-of-science
Korea-health-industry-development-institute
Professor-won-suk-chung
Biological-sciences
Korea-advanced-institute

Novel fusion protein drug for Alzheimer's disease circumvents the neurotoxic inflammatory side effects

Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA approved drug for Alzheimer's disease (AD) based on its ability to decrease Aβ plaque burden in AD patients, its effect on cognitive improvement is still controversial.

South-korea
Korea
Yeseong-choi
Chan-hyuk-kim
Young-lee
Emily-henderson
Minjin-kim
Hyuncheol-jung
Suk-chung
Hyeong-ryeol-choi
Korea-health-industry-development-institute
Department-of-biological-sciences

A new drug for Alzheimer's without inflammatory side effects

A new drug for Alzheimer's without inflammatory side effects
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

South-korea
Korea
Minjin-kim
Yeseong-choi
Hyuncheol-jung
Chan-hyuk-kim
Suk-chung
Hyeong-ryeol-choi
Young-lee
Korea-health-industry-development-institute
Department-of-biological-sciences
Ministry-of-health-welfare
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.